ClinCancerRes[Jour]AND27[volume]AND1[issue]
临床癌症研究27卷1期
1
CombinationswithAllostericSHP2InhibitorTNOtoBlockReceptorTyrosineKinaseSignaling.
与别构SHP2抑制剂TNO联合阻断受体酪氨酸激酶信号。
LiuC,LuH,WangH,LooA,ZhangX,YangG,KowalC,DelachS,WangY,GoldoniS,HastingsWD,WongK,GaoH,MeyerMJ,MoodySE,LaMarcheMJ,EngelmanJA,WilliamsJA,HammermanPS,AbramsTJ,MohseniM,CaponigroG,HaoHX.
ClinCancerRes.Jan1;27(1):-.
2
AnImmune-RelatedGenePrognosticIndexforHeadandNeckSquamousCellCarcinoma.
头颈部鳞状细胞癌的免疫相关基因预后指标。
ChenY,LiZY,ZhouGQ,SunY.
ClinCancerRes.Jan1;27(1):-.
3
SimilaritiesinRiskforCOVID-19andCancerDisparities.
COVID-19风险的相似性和癌症差异。
NewmanLA,WinnRA,CarethersJM.
ClinCancerRes.Jan1;27(1):24-27.
4
EfficacyandSafetyofNivolumabPlusIpilimumabversusSunitinibinFirst-lineTreatmentofPatientswithAdvancedSar
转载请注明：http://www.tzdgt.com/dynmllcbx/10708.html
